Product NDC: | 52125-525 |
Proprietary Name: | Avelox |
Non Proprietary Name: | moxifloxacin hydrochloride |
Active Ingredient(s): | 400 mg/1 & nbsp; moxifloxacin hydrochloride |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET, FILM COATED |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 52125-525 |
Labeler Name: | REMEDYREPACK INC. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA021085 |
Marketing Category: | NDA |
Start Marketing Date: | 20130524 |
Package NDC: | 52125-525-02 |
Package Description: | 30 TABLET, FILM COATED in 1 VIAL (52125-525-02) |
NDC Code | 52125-525-02 |
Proprietary Name | Avelox |
Package Description | 30 TABLET, FILM COATED in 1 VIAL (52125-525-02) |
Product NDC | 52125-525 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | moxifloxacin hydrochloride |
Dosage Form Name | TABLET, FILM COATED |
Route Name | ORAL |
Start Marketing Date | 20130524 |
Marketing Category Name | NDA |
Labeler Name | REMEDYREPACK INC. |
Substance Name | MOXIFLOXACIN HYDROCHLORIDE |
Strength Number | 400 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Quinolone Antimicrobial [EPC],Quinolones [Chemical/Ingredient] |